Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Influenza

Free Subscription 14.09.2026 1 Antimicrob Agents Chemother 1 BMC Pediatr 1 J Infect 2 J Virol Methods 5 PLoS Comput Biol 1 PLoS Med 8 PLoS One 1 Proc Natl Acad Sci U S A 34 Vaccine 3 Virology 1 Virus Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Antimicrob Agents Chemother

1. PENG Z, Yuan H, Huang J, Lin X, et al
   A novel ursodeoxycholic acid derivative exhibits broad-spectrum antiviral activity against influenza A virus and coronaviruses by multiphasic disruption of the viral life cycle.
   Antimicrob Agents Chemother. 2026 Sep 9:e0028426. doi: 10.1128/aac.00284.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

2. BOZZOLA E, Piccotti E, D'Auria E, Trapani S, et al
   RESPIRIAMO - Italian hospital surveillance for lower respiratory tract infections: a multicenter retrospective cohort study of respiratory syncytial virus-associated hospitalizations in children under 2 years of age.
   BMC Pediatr. 2026;26:853.
   PubMed         Abstract available
   
   

   
   J Infect

3. ZHU X, Deng Y, Xiao G, Zhang J, et al
   Re-emergence of H10N3 Avian Influenza Viruses in China: Evolutionary Dynamics and Emerging Zoonotic Risk.
   J Infect. 2026 Sep 7:106848. doi: 10.1016/j.jinf.2026.106848.
   PubMed        
   
   

   
   J Virol Methods

4. EZEANYAEGBU CN, Toledo NP, Corkum CP, Nelder M, et al
   Evaluation of one-step amplicon-based targeted enrichment for SARS-CoV-2 whole-genome sequencing using the Midnight amplicon scheme.
   J Virol Methods. 2026;346:115448.
   PubMed         Abstract available
   
   
5. KAZEMIAN S, Pedroza S, Santana-Pereira ALR, Neasham PJ, et al
   An enhanced multisegment RT-PCR method for influenza A virus sequencing: Improved performance and reduced preparation time over traditional methods.
   J Virol Methods. 2026;347:115453.
   PubMed         Abstract available
   
   

   
   PLoS Comput Biol

6. QUILTY BJ, Chapman LAC, Munday JD, Wong KLM, et al
   Disentangling the drivers of heterogeneity in SARS-CoV-2 transmission from data on viral load and daily contact rates.
   PLoS Comput Biol. 2026;22:e1014715.
   PubMed         Abstract available
   
   
7. SONG P, de Vlas SJ, Emery T, Coffeng LE, et al
   Mapping spatial colleague connectivity patterns from individual-level registry data to inform regional pandemic interventions.
   PLoS Comput Biol. 2026;22:e1014721.
   PubMed         Abstract available
   
   
8. PANT B, Lalovic M, Kiss IZ, Santillana M, et al
   The paradox of neglecting changes in behavior: How standard epidemic models misestimate both transmissibility and final epidemic size.
   PLoS Comput Biol. 2026;22:e1014746.
   PubMed         Abstract available
   
   
9. YUAN Z, Zhang X, Lin G, Zou Q, et al
   AET5: A transcriptome-guided molecular generation framework with contrastive self-supervised learning.
   PLoS Comput Biol. 2026;22:e1014703.
   PubMed         Abstract available
   
   
10. BENHAMOU W, Howerton E, Park SW, Viboud C, et al
    Leveraging perturbations to infer the population dynamics of human rhinovirus and interaction of influenza A virus.
    PLoS Comput Biol. 2026;22:e1014784.
    PubMed         Abstract available
    
    

    
    PLoS Med

11. LENGLART L, Titomanlio L, Alberti I, Almeida L, et al
    Association between nirsevimab coverage and pediatric emergency department visits for bronchiolitis in 12 European countries: An interrupted time-series analysis.
    PLoS Med. 2026;23:e1005223.
    PubMed         Abstract available
    
    

    
    PLoS One

12. KWON K, Jang CY, Kim W, Son J, et al
    Kinetics of the PASC Index in Long COVID.
    PLoS One. 2026;21:e0357670.
    PubMed         Abstract available
    
    
13. BATTU S, Moore AR, Lebold K, Pacheco-Navarro A, et al
    Outcomes of immunocompromised and non-immunocompromised patients in the ICU diverge late in the pandemic.
    PLoS One. 2026;21:e0357181.
    PubMed         Abstract available
    
    
14. JI M, Dong H, Xu Y, Wang Y, et al
    Development of a multiplex real-time PCR assay with fluorescence probe-melting-curve analysis for one-tube detection of respiratory pathogens.
    PLoS One. 2026;21:e0357377.
    PubMed         Abstract available
    
    
15. GONG X, Liu L, Lu Y, Zhang G, et al
    Sleepless in America: A social sensing study of pandemic-era sleeplessness using nighttime social media data.
    PLoS One. 2026;21:e0356547.
    PubMed         Abstract available
    
    
16. BHATIA A, Elser J, Carrell SJ, Kronmiller B, et al
    Correlation assessment of SARS-CoV-2 variants and their subvariants present in clinical and wastewater samples in Oregon, USA (February 7, 2021 - February 26, 2022) using the Freyja bioinformatics approach.
    PLoS One. 2026;21:e0357591.
    PubMed         Abstract available
    
    
17. MOHD YUSOFF H, Yew SQ, Mohd Nawi A, Mohd Tohit N, et al
    Prevalence and risk factors of adverse work outcomes among manufacturing workers with Long COVID in Malaysia - A nationwide study.
    PLoS One. 2026;21:e0357125.
    PubMed         Abstract available
    
    
18. VALDES-LOPEZ JF, di Filippo D, Penagos S, Hernandez-Sarmiento LJ, et al
    SARS-CoV-2 infection induces functional impairment of vitamin D receptor signaling to drive interleukin 6-dependent hyperinflammation in mononuclear phagocytes.
    PLoS One. 2026;21:e0357030.
    PubMed         Abstract available
    
    
19. AMARSANAA J, Nguyen TXT, Khan MSR, Kadoya Y, et al
    The dynamics of loneliness: A longitudinal exploration of transitions in Japan across the COVID-19 period, 2020-2024.
    PLoS One. 2026;21:e0358269.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

20. LI L, Nguyen L, Qu H, Wu Q, et al
    Increased receptor binding and spike glycosylation, remodeled immune escape of surging SARS-CoV-2 subvariant BA.3.2.2/RE.2.2/Cicada.
    Proc Natl Acad Sci U S A. 2026;123:e2614163123.
    PubMed         Abstract available
    
    

    
    Vaccine

21. BUCKLIN R, Gauthreaux N, Faber E, Askelson N, et al
    Listening to micropolitan community leaders to support pandemic response efforts.
    Vaccine. 2025;60 Suppl 1:127255.
    PubMed         Abstract available
    
    
22. HOLLIDAY RC, Darkwa A, Brooks GA, Akintobi TH, et al
    Developing counter-narratives to address COVID-19 misinformation among 18-24 year olds in community and campus settings.
    Vaccine. 2025;60 Suppl 1:127135.
    PubMed         Abstract available
    
    
23. HEIMAN SL, Geiger N
    Overestimation of racial ingroup worry about the COVID-19 vaccine and medical racism.
    Vaccine. 2026;91:129046.
    PubMed         Abstract available
    
    
24. DUTTA S, Ngemera D, Jaillard P, Juneja S, et al
    Lessons learnt from one-year cold chain support for COVID-19 vaccination in 5 middle income countries of North Africa.
    Vaccine. 2026;91:128994.
    PubMed         Abstract available
    
    
25. CAMPBELL STATLER M, Bishop-Royse J, Sampson AT, Martin M, et al
    Heterogeneity among the vaccine hesitant: A secondary analysis of the national CEAL Common Survey data.
    Vaccine. 2026;91:129024.
    PubMed         Abstract available
    
    
26. KIM SJ, Kim HW, Son SE, Song JH, et al
    Wuhan-ancestral multi-antigen SARS-CoV-2 virus-like particles protect against the omicron sublineage JN.1 variant.
    Vaccine. 2026;91:129059.
    PubMed         Abstract available
    
    
27. FAHFOUHI Y, Fievez S, Cohen R, Levy C, et al
    A health-economic assessment of the impact of different RSVpreF maternal vaccine strategies to prevent RSV infections among young infants, in France: EPIPACT.
    Vaccine. 2026;91:129036.
    PubMed         Abstract available
    
    
28. BERIKOPOULOU MM, Tatsi EB, Siahanidou T, Michos A, et al
    Systematic review of the mutations in the active antigenic site O of the prefusion F protein of the Respiratory Syncytial Virus (RSV) following the implementation of monoclonal antibody prophylaxis.
    Vaccine. 2026;91:129069.
    PubMed         Abstract available
    
    
29. NUNES JPDS, Daher IP, Pires ADS, Yamamoto MM, et al
    Synergistic effect of AddaS03 and poly I:C adjuvants on antibody titers and Th1-biased T cell responses following RBD vaccination in BALB/c mice.
    Vaccine. 2026;91:129073.
    PubMed         Abstract available
    
    
30. MONOI A, Endo A, Kriznar M, Suzuki M, et al
    Comparing the potential impacts of seasonal immunisation against year-round immunisation to prevent RSV infant hospitalisations in Japan: A modelling study.
    Vaccine. 2026;91:129079.
    PubMed         Abstract available
    
    
31. SCHRARSTZHAUPT IN, Diaz-Quijano FA
    Effectiveness of COVID-19 vaccination schedules against severe COVID-19 in children aged 6 months to 4 years in Brazil: A population-based cohort study (2023-2024).
    Vaccine. 2026;91:129096.
    PubMed         Abstract available
    
    
32. ALAMI A, Lewis M, El-Chaar D, Walker M, et al
    Maternal vaccination with RSVpreF and risk of hypertensive disorders of pregnancy: a systematic review and meta-analysis.
    Vaccine. 2026;91:129070.
    PubMed         Abstract available
    
    
33. DENG L, Ye X, Chen X, Hu X, et al
    Secretory expression of tetrameric neuraminidase enhanced by signal peptide optimization elicits robust immunity against influenza infection in mice.
    Vaccine. 2026;92:129118.
    PubMed         Abstract available
    
    
34. SANBORN J, Robertson MM, Penrose K, Rane M, et al
    Gaps between willingness and uptake of influenza and COVID-19 vaccines during the 2025-26 respiratory virus season in a U.S. adult cohort.
    Vaccine. 2026;92:129126.
    PubMed         Abstract available
    
    
35. LU J, Ouyang Z, Huang F, Xie X, et al
    Real-world effectiveness of the influenza vaccine among school-aged children in Shenzhen, China, 2024-2025 season: A test-negative design study.
    Vaccine. 2026;92:129100.
    PubMed         Abstract available
    
    
36. THAKKAR V, Aryan Y, Gautam S, Joshi R, et al
    Influence of vaccine delivery route on immune imprinting in influenza vaccination.
    Vaccine. 2026;92:129109.
    PubMed         Abstract available
    
    
37. TORAIH EA, Hussein MH, Thomas SJ, Aiash H, et al
    Cardiac outcomes following SARS-CoV-2 infection versus BNT162b2 vaccination in adolescents and young adults: a cohort study of 4 million individuals.
    Vaccine. 2026;91:129001.
    PubMed         Abstract available
    
    
38. CABURNAY CA, Fu QJ, Carter T, Butler T, et al
    Identification of best outreach strategies and delivery modalities for population subgroups for COVID-19 vaccination.
    Vaccine. 2026;60 Suppl 1:128721.
    PubMed         Abstract available
    
    
39. CANACA G, Vicuna B, Hess JM, Cruz TH, et al
    From engagement to ownership: a qualitative study of a community-academic partnership to promote COVID-19 vaccine confidence among Latino/Hispanic communities in New Mexico.
    Vaccine. 2026;60 Suppl 1:128583.
    PubMed         Abstract available
    
    
40. STIEHL E, Negrete M, Flores G, Federmeyer L, et al
    Empowering communities during the COVID-19 pandemic: insights from trusted messengers about their work addressing COVID-19 vaccine hesitancy.
    Vaccine. 2026;60 Suppl 1:128559.
    PubMed         Abstract available
    
    
41. NUNO T, Soto S, Sepulveda R, Sierra LA, et al
    The Arizona prevention research center vaccine confidence network: A Mobile health unit intervention and survey results of barriers and facilitators to COVID-19 vaccination.
    Vaccine. 2025;60 Suppl 1:127970.
    PubMed         Abstract available
    
    
42. HARA-HUBBARD KK, Beaulieu A, Mendiola A, Gandhi P, et al
    Strategies for addressing COVID-19 vaccine equity with intermediaries, prevention research centers, and the vaccine confidence network.
    Vaccine. 2025;60 Suppl 1:127847.
    PubMed         Abstract available
    
    
43. CHUVILEVA YE, Kuiper NM, Ramakrishnan A, Goodman K, et al
    Weaving a public health network: Process and results from an evaluation of CDC's Prevention Research Centers Vaccine Confidence Network.
    Vaccine. 2025;60 Suppl 1:127636.
    PubMed         Abstract available
    
    
44. ALMUKHTAR S, McWhirter N, Mendiola A, Samuel S, et al
    Exploring lingering COVID-19 vaccine hesitancy in three diverse U.S. states: Alabama, Illinois, and Texas.
    Vaccine. 2025;60 Suppl 1:127664.
    PubMed         Abstract available
    
    
45. BEAULIEU A, LaMonaca K, Higginbottom J, Foster J, et al
    Utilizing the Program Impact Pathways framework for improving COVID-19 vaccine confidence and uptake: demonstrations of multi-sector collaboration from two geographies in Connecticut.
    Vaccine. 2025;60 Suppl 1:127623.
    PubMed         Abstract available
    
    
46. JEFFERS A, Kuiper NM, Ramakrishnan A, Swarna H, et al
    Building trust in community-academic partnerships: Strategies for enhancing vaccine confidence and demand - Lessons from Prevention Research Centers.
    Vaccine. 2025;60 Suppl 1:127624.
    PubMed         Abstract available
    
    
47. MCGEE RE, Barrett DA, Bednarczyk RA, Grant-Whitlock M, et al
    Engaging rural and non-Hispanic Black persons in conversations about the COVID-19 vaccine: a process evaluation of a natural helper intervention.
    Vaccine. 2025;60 Suppl 1:127587.
    PubMed         Abstract available
    
    
48. BORG A, Goulding M, Minkah P, Perrone D, et al
    Promotion of COVID-19 vaccination for youth and families in Worcester, Massachusetts: a Diffusion of Innovations approach.
    Vaccine. 2025;60 Suppl 1:127586.
    PubMed         Abstract available
    
    
49. SAVAS LS, Cuccaro P, Zhang K, Hernandez R, et al
    Factors influencing COVID-19 vaccine uptake among vulnerable communities in Texas: Perceptions of 2-1-1 helpline callers.
    Vaccine. 2025;60 Suppl 1:127554.
    PubMed         Abstract available
    
    
50. TOTZKAY D, Fraustino JD, Costello LM, Jarrett T, et al
    Building on West Virginia's innovative COVID-19 public health communication: associations between vaccination beliefs and vaccination messaging, partisanship, and social vulnerability.
    Vaccine. 2025;60 Suppl 1:127555.
    PubMed         Abstract available
    
    
51. O'CONNOR MH, Nyman AL, Ali S, Rothenberg R, et al
    Increasing vaccine uptake in a refugee resettlement community with high social vulnerability.
    Vaccine. 2025;60 Suppl 1:127552.
    PubMed         Abstract available
    
    
52. STIEHL E, Borg A, Cullen JP, Mendiola A, et al
    Engaging trusted messengers in public health response: Key strategies to building community trust among CDC'S prevention research center's vaccine confidence network.
    Vaccine. 2025;60 Suppl 1:127474.
    PubMed         Abstract available
    
    
53. HARA-HUBBARD KK, Flores Moreno MG, Sanchez M, Abdi N, et al
    The partnership for vaccine confidence: community-academic partnerships to promote COVID-19 vaccines to underserved urban and rural communities using the listen, plan, act, evaluate process.
    Vaccine. 2025;60 Suppl 1:127487.
    PubMed         Abstract available
    
    
54. MALLICK K, Handunge VL, Emmons KM, Blondet L, et al
    Engaging a community health ambassador model to promote COVID-19 vaccine in three Massachusetts communities.
    Vaccine. 2025;60 Suppl 1:127464.
    PubMed         Abstract available
    
    

    
    Virology

55. ISHIGAKI H, Otaki K, Kitagawa N, Ishida H, et al
    Pathogenicity of SARS-CoV-2 Omicron subvariants JN.1, EG.5.1, and BA.2.86.1 in immunologically naive cynomolgus macaques.
    Virology. 2026;624:111036.
    PubMed         Abstract available
    
    
56. LIU Z, Fan M, Zheng Y, Zeng Y, et al
    Transcriptome screening identifies circRNA-INSR as a novel host factor associated with avian influenza virus replication.
    Virology. 2026;625:111072.
    PubMed         Abstract available
    
    
57. MILLER AK, Heremia L, Waller SJ, Blanchard SL, et al
    Evaluating sampling strategies for the detection of avian influenza viruses in the environment.
    Virology. 2026;625:111069.
    PubMed         Abstract available
    
    

    
    Virus Res

58. ZHAO Y, Fan H
    Clinical impact of baloxavir-induced PA I38T/M substitutions in diverse influenza populations: a systematic review and meta-analysis.
    Virus Res. 2026;373:199797.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum